Literature DB >> 26983009

Psychological Stress and Depression: Risk Factors for IBD?

Charles N Bernstein1.   

Abstract

While it is widely accepted that chronic diseases such as inflammatory bowel disease (IBD) may trigger negative psychological emotions such as distress and even depression, it is unknown if this response to a chronic illness like IBD is solely a psychological response to an adverse situation or whether it also represents a biological response, that is, the active inflammatory state of IBD intersecting with the pathobiology of what mediates mood and anxiety disorders. There is a bi-directionality between psychological comorbidity and IBD with each influencing the course of the other when they coexist. Furthermore, there is much to learn in terms of the underlying pathobiology of depression and anxiety and how this may impact on the pathobiology of IBD. Several important questions in regards to psychological comorbidity and IBD will be reviewed in this chapter.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26983009     DOI: 10.1159/000442929

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  21 in total

1.  Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn's Disease?

Authors:  Lawrence S Gaines; James C Slaughter; David A Schwartz; Dawn B Beaulieu; Sara N Horst; Robin L Dalal; Elizabeth A Scoville; Robert S Sandler; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2020-02-11       Impact factor: 5.325

2.  The Relationship Between Adverse Childhood Experiences and Health Care Use in the Manitoba IBD Cohort Study.

Authors:  Kelcie M Witges; Charles N Bernstein; Kathryn A Sexton; Tracie Afifi; John R Walker; Zoann Nugent; Lisa M Lix
Journal:  Inflamm Bowel Dis       Date:  2019-09-18       Impact factor: 5.325

3.  The Alleviation of Gut Microbiota-Induced Depression and Colitis in Mice by Anti-Inflammatory Probiotics NK151, NK173, and NK175.

Authors:  Jong-Wook Yoo; Yoon-Jung Shin; Xiaoyang Ma; Young-Hoo Son; Hyo-Min Jang; Chang Kyun Lee; Dong-Hyun Kim
Journal:  Nutrients       Date:  2022-05-16       Impact factor: 6.706

Review 4.  Sex Differences in the Gut-Brain Axis: Implications for Mental Health.

Authors:  Calliope Holingue; Alexa Curhan Budavari; Katrina M Rodriguez; Corina R Zisman; Grace Windheim; M Daniele Fallin
Journal:  Curr Psychiatry Rep       Date:  2020-11-20       Impact factor: 5.285

Review 5.  Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist.

Authors:  Emily Weaver; Eva Szigethy
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

6.  The Rating Form of IBD Patient Concerns: Translation, Validation, and First Implementation of the Greek Version.

Authors:  Konstantinos Argyriou; Eleftheria Roma; Andreas Kapsoritakis; Eirini Tsakiridou; Konstantinos Oikonomou; Anastassios Manolakis; Spyridon Potamianos
Journal:  Gastroenterol Res Pract       Date:  2017-04-25       Impact factor: 2.260

7.  Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease.

Authors:  Jung Won Lee
Journal:  Gut Liver       Date:  2017-07-15       Impact factor: 4.519

8.  Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases.

Authors:  Marcus A Gray; Che-Yung Chao; Heidi M Staudacher; Natasha A Kolosky; Nicholas J Talley; Gerald Holtmann
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

Review 9.  Preventive health measures in inflammatory bowel disease.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

10.  Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn's disease patients.

Authors:  Thomas Greuter; Yannick Franc; Matthias Kaelin; Alain M Schoepfer; Philipp Schreiner; Jonas Zeitz; Michael Scharl; Benjamin Misselwitz; Alex Straumann; Stephan R Vavricka; Gerhard Rogler; Roland von Känel; Luc Biedermann
Journal:  Therap Adv Gastroenterol       Date:  2018-02-19       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.